BOBarbara Orlando

Barbara Orlando

*This is an algorithmically generated author record based on publicly available information.

Barbara Orlando has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimal Dose of Spinal Bupivacaine on Maternal and Fetal Outcomes in Parturients Undergoing Combined Technique for Labor Analgesia: A Randomized Double Blinded Prospective Study

    by Barbara S. Orlando, Deborah Stein, Jacqueline Donovan, Jason White, Ivan Bandovic, Pradeepan Ananthasingam, Hung-Mo Lin, Julio Marenco, Migdalia Saloum, Bryan Mahoney, et al.

    Study Objectives: Maternal hypotension and fetal bradycardia (FB) are recognized complications of combined spinal epidural. Our purpose was to ascertain which of 3 common doses of spinal bupivacaine results in optimal analgesia with minimal side effects, assuming the lowest dose fills all criteria. Design: Prospective, randomized clinical trial. Setting: Labor and Delivery Unit of 514-bed urban teaching hospital. Patients, Interventions and Measurements: Patients were assigned to receive an intrathecal dose of 20 mcg of fentanyl with either 2.5 mg, 1.66 mg, or 1.25 mg of isobaric bupivacaine. Visual Analog Scale (VAS) Pain Score, fetal heart rate (FHR), maternal blood pressure (BP), number of hypotensive episodes, doses of vasopressors, nitroglycerin and mode of delivery were recorded at various time points. Main results: 164 patients were enrolled: 66 receiving 1.25 mg, 50 in the 1.66 mg group and 48 in the 2.5 mg. At 6 and 10 minutes, we recorded in the 1.66 mg group: 4.7% and 4.6%, 18.9% and 23.9% fewer hypotensive episodes compared with the 1.25 mg and the 2.5 mg groups respectively and significantly more hypotensive episodes in the 2.5 mg group (p = 0.025 and 0.019 respectively). There was no statistical difference in vasopressors use, mode of delivery or FB. The VAS decreased equally by an average of 7–10 points among all groups. Conclusion: The 1.66 mg spinal dose was associated with the least hypotensive episodes and equivalent pain relief as the 2.5 mg. The 1.25 mg and 1.66 mg doses allowed for adequate BP and FHR stability. Clinical Trial: Study registered on the ClinicalTrial.gov website under the NCT number NCT02159807.

  • Well-Being in Anesthesiology Graduate Medical Education

    by Lauren Lisann-Goldman, Christopher Cowart, Hung-Mo Lin, Barbara Orlando, Bryan Mahoney


  • Subdural catheter placement resulting in inadequate blocks: Two case reports

    by Christopher R. Cowart, Barbara S. Orlando, Deborah Stein, Bryan Mahoney

  • Nitrous Oxide Use During Labor: Satisfaction, Adverse Effects, and Predictors of Conversion to Neuraxial Analgesia

    by Priscilla M. Nodine, Michelle R. Collins Cnm, Cristina L. Wood, Jessica L. Anderson, Barbara S. Orlando, Bryan K. McNair, David C. Mayer, Deborah J. Stein

    Introduction: Women desire safe and effective choices for pain management during labor. Currently, neuraxial and opioid analgesia are the most common methods used in the United States. The purpose of this study was to investigate demographic characteristics, safety, and satisfaction in a cohort of parturients who used inhaled nitrous oxide (N2O) analgesia and to determine predictors of conversion from N2O to neuraxial analgesia.Methods: This was a prospective chart review study. Individuals aged at least 18 years who used inhaled N2O during the first or second stage of labor between March 1, 2016, and July 23, 2017, on the labor and delivery unit of one academic medical center (N = 463) and their neonates were included. Data describing maternal and neonatal factors are reported. Logistic regression and chi‐square tests were used to model the effects of oxytocin augmentation, labor induction, parity, prior cesarean birth, pre‐N2O cervical dilatation, and post‐N2O cervical dilatation on the odds of conversion from N2O to neuraxial analgesia.Results: In this cohort, 31% who chose N2O for analgesia did not convert to any other analgesic method. Significant positive predictors for conversion from N2O to neuraxial analgesia included labor induction (odds ratio [OR], 2.9; 95% CI, 1.7‐5.0), oxytocin augmentation (OR, 3.1; 95% CI, 1.6‐6.0), and labor after cesarean (OR, 6.4; 95% CI, 2.5‐16.5). Multiparity (OR, 0.4; 95% CI, 0.2‐0.6) and post‐N2O cervical dilatation (OR, 0.8; 95% CI, 0.7‐0.9) were negative predictors. Adverse effects related to N2O use during labor were rare (8%) and were not a significant reason for conversion to neuraxial analgesia. Parturients had moderately high satisfaction with N2O for pain management (11‐point scale, mean [SD], 7.4 [2.9]). Five‐minute Apgar scores were 7 or greater in 97.8% of the newborns.Discussion: Understanding predictors of conversion from inhaled N2O to neuraxial analgesia may assist perinatal care providers in their discussions with women about analgesia options during labor. N2O is a useful, safe option for labor analgesia in the United States.


  • Anesthetic management of parturients with Arnold Chiari malformation-I: a multicenter retrospective study

    by T.R. Gruffi, F.M. Peralta, M.S. Thakkar, A. Arif, R.F. Anderson, B. Orlando, J.C. Coffman, N. Nathan, R.J. McCarthy, P. Toledo, et al.


    • 1 January 2018
      • Vol. 20  (1) , E619

    A Program Director Survey of the Clinical Base Year in Anesthesiology Residency Programs.

    by Agathe Streiff, Barbara Orlando, Bryan Mahoney

    To maintain compliance with the current shift towards competency-based milestone assessment in graduate medical education, residency training programs must reflect this emphasis in their curricula starting with the intern year of training.1 In working towards collaborative efforts in curricular development between Accreditation Council for Graduate Medical Education (ACGME) anesthesiology residency programs, understanding the structure and design of the clinical base year for anesthesiology residency programs nationwide will serve as a valuable initial step. Anonymous online surveys were sent to anesthesiology residency program directors to collect data regarding their program's anesthesiology clinical base year (CBY) required, elective, and novel rotations. The survey was also designed to characterize the educational resources provided by the department, changes in the design of the clinical base year, and the feedback received from interns or other rotation department heads. Thirty-nine out of 130 US anesthesiology residency program directors responded (30%). The majority of respondents (87%) provide an in-house categorical intern CBY with a majority of those (94%) including a month dedicated to anesthesiology, during which some form of mentorship by anesthesiology faculty or senior house staff was provided. The majority of respondents with anesthesiology exposure stated that they provide educational resources such as textbook materials (82%) or simulation sessions (89%) to their residents. With the evolution of the role of the anesthesiologist, advancements in biotechnology, and newly created board examinations, it is imperative that the CBY prepares rising anesthesiology residents to meet these demands. Results from this survey study can serve as the initial step in improving the clinical base year structure for anesthesiology residents nationally. Collaborative efforts can be undertaken to better incorporate clinical competency, feedback mechanisms, and educational tools through the collection of experiential evidence of successful strategies as well as challenges faced by program directors nationwide.